Protection against aflatoxin B1 in rat--a new look at the link between toxicity, carcinogenicity, and metabolism.
Ellis
Elizabeth M
EM
Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G11XW, UK. Elizabeth.ellis@strath.ac.uk
D016604:Aflatoxin B1 / Q000378:metabolism* / Q000493:pharmacokinetics / Q000633:toxicity*; D000449:Aldehyde Reductase / Q000235:genetics / Q000378:metabolism*; D000818:Animals; D030801:Animals, Genetically Modified; D001231:Aspergillus flavus / Q000378:metabolism; D002273:Carcinogens / Q000378:metabolism / Q000493:pharmacokinetics / Q000633:toxicity*; D018736:DNA Adducts / Q000378:metabolism; D004195:Disease Models, Animal; D008658:Inactivation, Metabolic; D008113:Liver Neoplasms / Q000139:chemically induced* / Q000378:metabolism; D051381:Rats
D002273:Carcinogens; D018736:DNA Adducts; D016604:Aflatoxin B1; C442302:AKR7A1; D000449:Aldehyde Reductase